Expanded LUXendin Color Palette for GLP1R Detection and Visualization In Vitro and In Vivo (2022)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/jacsau.2c00130
PubMed Identifier: 35557759
Publication URI: http://europepmc.org/abstract/MED/35557759
Type: Journal Article/Review
Parent Publication: JACS Au
Issue: 4
ISSN: 2691-3704